sulmazole has been researched along with Alloxan Diabetes in 1 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Utkan, T | 1 |
| Yildirim, MK | 1 |
| Yildirim, S | 1 |
| Sarioglu, Y | 1 |
1 other study available for sulmazole and Alloxan Diabetes
| Article | Year |
|---|---|
Effects of the specific phosphodiesterase inhibitors on alloxan-induced diabetic rabbit cavernous tissue in vitro.
Topics: Amrinone; Animals; Diabetes Mellitus, Experimental; Erectile Dysfunction; Imidazoles; Male; Muscle C | 2001 |